You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 July 2020 - Biotechnology company Entera Health reported on Thursday the receipt of the IRB approval to commence a clinical trial in Barcelona Spain using EnteraGam to manage the symptoms associated with COVID-19 infections in partnership with Lemu...
3 July 2020 - CNN reported on Friday that a global study has found strong evidence that a mutated new form of COVID-19 virus has spread from Europe to the US.This mutation makes the virus more likely to infect people but does not seem to make them an...
3 July 2020 - CNN reported on Friday that the US Food and Drug Administration authorised a new test that diagnoses both influenza and for COVID-19, CNN reported on Friday.The test, designed by the US Centers for Disease Control and Prevention (CDC), ...
3 July 2020 - Investment firm KKR & Co Inc (NYSE:KKR) reported on Thursday that it has entered into a definitive agreement to purchase a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd (NSE:JBCHEPHARM), subject to regulatory and oth...
2 July 2020 - - The European Commission has approved ULTOMIRIS (ravulizumab), a long-acting C5 complement inhibitor administered every eight weeks, for the treatment of adults and children with a body weight of 10 kg or above with atypical hemol...
2 July 2020 - - US-based biotechnology company Cancer Prevention Pharmaceuticals, Inc has submitted a New Drug Application to the US Food and Drug Administration seeking accelerated approval for CPP-1X/sul for treatment of adults with familial adenom...
2 July 2020 - - The Japanese Ministry of Health, Labour and Welfare approved Tabrecta (capmatinib) for MET exon 14 skipping (METex14) mutation-positive advanced and/or recurrent unresectable non-small cell lung cancer (NSCLC), US-based Incyte (NASDAQ...